Wikidata

(Q51451492)

English

Treatment persistence with monthly zoledronic acid is associated with lower risk and frequency of skeletal complications in patients with breast cancer and bone metastasis.

scientific article published on 3 May 2011

In more languages

Statements

title
Treatment persistence with monthly zoledronic acid is associated with lower risk and frequency of skeletal complications in patients with breast cancer and bone metastasis. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21665138
retrieved
5 April 2018
reference URL
http://europepmc.org/abstract/MED/21665138

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q51451492&oldid=1516350443"